AstraZeneca to create 100 jobs in new Dublin plant
Medicines | Alexion
Swedish rare disease drugmaker Sobi to go private in $8B takeover by Advent, GIC | Fierce Pharma
Medicines | Alexion
Alexion Pharmaceuticals, Inc. | LinkedIn
Alexion Pharmaceuticals, Inc. | LinkedIn
AstraZeneca's Alexion buy will add capacity - Bioprocess InsiderBioProcess International
Alexion
Alexion adds to pipeline rebuild with $855m Wilson buy - PMLiVE
Alexion (ALXN) to Acquire Wilson Therapeutics for $855M
With approval for new drug, Alexion aims to switch patients from Soliris
Ultomiris brings more good news for AstraZeneca with NMOSD data
Alexion
Alexion
AstraZeneca's sales rise as CEO hails transformational Alexion deal
Alexion
Alexion
Medicines | Alexion
Alexion
AstraZeneca to buy Boston biotech Alexion for $39 billion in rare-disease push - The Boston Globe
Alexion inks $855M takeover of Wilson Therapeutics | Fierce Biotech
AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial Development | Business Wire
Alexion Purchases Wilson Therapeutics for $855M: Expands Pipeline | BioSpace
Alexion
